Adjuvant effect of Bacillus firmus on the expression of cytokines and toll-like receptors in mouse nasopharynx-associated lymphoid tissue (NALT) after intranasal immunization with inactivated influenza virus type A

Immunology Letters

Volumn 134, Issue 1, 2010, Pages 26-34

  Zanvit, Peter ^a   Tichopád, Aleš ^b   Havlíčková, Martina ^c   Novotná, Olga ^a   Jirkovská, Marie ^a   Kološtová, Katarína ^a   Čechová, Dana ^a   Julák, Jaroslav ^a   Šterzl, Ivan ^a   Prokešová, Ludmila ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Multimarker gene expression; Nasopharynx associated lymphoid tissue (NALT); Toll like receptors (TLR)

Indexed keywords

ALPHA INTERFERON 4; BETA INTERFERON; CHEMOKINE RECEPTOR CCR7; CYTOKINE; DELIPIDATED BACILLUS FIRMUS ADJUVANT; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INACTIVATED INFLUENZA VIRUS A(H1N1) VACCINE; INACTIVATED VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLUENZA VACCINE; INTERFERON; INTERFERON ALPHA11; INTERFERON ALPHA12; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACILLUS; BACILLUS FIRMUS; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; LYMPHOID TISSUE; MONOTHERAPY; MOUSE; MUCOSAL IMMUNITY; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; POLARIZATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH1 CELL POLARIZATION; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACILLUS; CYTOKINES; DRUG SYNERGISM; GENE EXPRESSION; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTERFERON TYPE I; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOID TISSUE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NASOPHARYNX; PRINCIPAL COMPONENT ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 78049317159     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.08.006     Document Type: Article

References (33)

1. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 1984, 14(April (4)):350-356.
2. Waldman R.H., Wigley F.M., Small P.A. Specificity of respiratory secretion antibody against influenza virus. J Immunol 1970, 105(December (6)):1477-1483.
3. Hoffmann E., Mahmood K., Chen Z., et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol 2005, 79(September (17)):11014-11021.
4. Hunter R.L. Overview of vaccine adjuvants: present and future. Vaccine 2002, 20(May (Suppl. 3)):S7-12.
5. Ulmer J.B., Valley U., Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol 2006, 24(November (11)):1377-1383.
6. Zanvit P., Havlickova M., Tacner J., Jirkovska M., Petraskova P., Novotna O., et al. Immune response after adjuvant mucosal immunization of mice with inactivated influenza virus. Immunol Lett 2005, 97(March (2)):251-259.
7. Zanvit P., Havlickova M., Tacner J., Novotna O., Jirkovska M., Cechova D., et al. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant. Immunol Lett 2008, 115(January (2)):144-152.
8. Kraal Georg Nasal-associated lymphoid tissue. Mucosal immunology 2005, Elsevier, p. 415-22. 3rd ed.
9. Kuper C.F., Koornstra P.J., Hameleers D.M., Biewenga J., Spit B.J., Duijvestijn A.M., et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992, 13(June (6)):219-224.
10. Cesta M.F. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol 2006, 34(5):599-608.
11. Carroll K.K., Cutts J.H., Murray E.G. The lipids of Listeria monocytogenes. Can J Biochem 1968, 46(August (8)):899-904.
12. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226(May (1)):497-509.
13. Asanuma H., Thompson A.H., Iwasaki T., Sato Y., Inaba Y., Aizawa C., et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J ImmunolMethods 1997, 202(March (2)):123-131.
14. Kubista M., Sindelka R., Tichopad A., Bergkvist A., Lindh D., Forootan A. The prime technique. Real-time PCR data analysis. GIT Lab J 2007, 9/10(33-35).
15. -ΔΔCT method. Methods 2001, 25:402-408.
16. Prokesova L., Novakova M., Julak J., Mara M. Effect of Bacillus firmus and other sporulating aerobic microorganisms on in vitro stimulation of human lymphocytes. A comparative study. Folia Microbiol (Praha) 1994, 39(6):501-504.
17. Prokesova L., Mlckova P., Stankova I., Chloubova A., Novotna V., Ladmanova P., et al. Effect of Bacillus firmus on antibody formation after mucosal and parenteral immunization in mice. Immunol Lett 1998, 64(December (2/3)):161-166.
18. Prokesova L., Mlckova P., Stankova I., Ladmanova P., Jezkova J., Chalupna P., et al. Immunostimulatory effect of Bacillus firmus on mouse lymphocytes. Folia Microbiol (Praha) 2002, 47(2):193-197.
19. Zidek Z., Tuckova L., Mara M., Barot-Ciorbaru R., Prokesova L., Tlaskalova-Hogenova H. Stimulation of macrophages by Bacillus firmus: production of nitric oxide and cytokines. Int J Immunopharmacol 1998, 20(July (7)):359-368.
20. Mlckova P., Cechova D., Chalupna P., Novotna O., Prokesova L. Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intratracheal immunisation using Bacillus firmus as an adjuvant. Immunol Lett 2001, 77(May (1)):39-45.
21. Mlckova P., Polacek M., Cechova D., Maruskova L., Stankova I., Chalupna P., et al. Intratracheal and intranasal immunization with ovalbumin conjugated with Bacillus firmus as a carrier in mice. Folia Microbiol (Praha) 2005, 50(3):247-253.
22. Kuper C.F., Hameleers D.M., Bruijntjes J.P., van der Ven I., Biewenga J., Sminia T. Lymphoid and non-lymphoid cells in nasal-associated lymphoid tissue (NALT) in the rat. An immuno- and enzyme-histochemical study. Cell Tissue Res 1990, 259(February (2)):371-377.
23. Hiroi T., Iwatani K., Iijima H., Kodama S., Yanagita M., Kiyono H. Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur J Immunol 1998, 28(October (10)):3346-3353.
24. Yanagita M., Hiroi T., Kitagaki N., Hamada S., Ito H.O., Shimauchi H., et al. Nasopharyngeal associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 1999, 162(March (6)):3559-3565.
25. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4(July (7)):499-511.
26. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303(March (5663)):1529-1531.
27. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408(December (6813)):740-745.
28. Uematsu S., Akira S. Toll-like receptors and Type I interferons. J Biol Chem 2007, 282(May (21)):15319-15323.
29. Van Pesch V., Lanaya H., Renauld J.C., Michiels T. Characterization of the murine alpha interferon gene family. J Virol 2004, 78(August (15)):8219-8228.
30. Van H.M., Bosveld I.J., Mooren A.A., Trapman J., Zwarthoff E.C. Properties of natural and hybrid murine alpha interferons. J Gen Virol 1986, 67(October (Pt 10)):2215-2222.
31. Van H.M., Bosveld I.J., Klaassen P., Zwarthoff E.C., Trapman J. Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons. J Interferon Res 1988, 8(February (1)):5-14.
32. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17(November (22)):6660-6669.
33. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13(October (4)):539-548.